表紙
市場調査レポート

鼻閉:世界の治験動向

Nasal Congestion Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 235286
出版日 ページ情報 英文 71 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
鼻閉:世界の治験動向 Nasal Congestion Global Clinical Trials Review, H2, 2015
出版日: 2015年07月15日 ページ情報: 英文 71 Pages
概要

当レポートでは、鼻閉の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 鼻閉
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:呼吸器系疾患治療薬の治験における鼻閉の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患治療薬の治験における鼻閉の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

鼻閉治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Pfizer Inc.
    • Novartis AG
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Merck シャープ & Dohme Corp. (Inactive)
    • McNEIL-PPC, Inc.
    • Bayer AG
    • Ache Laboratorios Farmaceuticos S/A
    • BioCryst Pharmaceuticals, Inc.
    • Acura Pharmaceuticals, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Bronx-Lebanon Hospital Center
    • California Pacific Medical Center Research Institute
    • University of Chicago
    • University of South Florida
    • University of Washington

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2773CTIDB

GlobalData's clinical trial report, "Nasal Congestion Global Clinical Trials Review, H2, 2015" provides an overview of Nasal Congestion clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Congestion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nasal Congestion
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Nasal Congestion to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nasal Congestion to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nasal Congestion
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Nasal Congestion Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Merck Sharp & Dohme Corp. (Inactive)
      • Clinical Trial Overview of Merck Sharp & Dohme Corp. (Inactive)
      • McNEIL-PPC, Inc.
      • Clinical Trial Overview of McNEIL-PPC, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Ache Laboratorios Farmaceuticos S/A
      • Clinical Trial Overview of Ache Laboratorios Farmaceuticos S/A
      • BioCryst Pharmaceuticals, Inc.
      • Clinical Trial Overview of BioCryst Pharmaceuticals, Inc.
      • Acura Pharmaceuticals, Inc.
      • Clinical Trial Overview of Acura Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Bronx-Lebanon Hospital Center
      • Clinical Trial Overview of Bronx-Lebanon Hospital Center
      • California Pacific Medical Center Research Institute
      • Clinical Trial Overview of California Pacific Medical Center Research Institute
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • University of Washington
      • Clinical Trial Overview of University of Washington
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nasal Congestion Therapeutics, Global, Clinical Trials by Region, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Nasal Congestion to Respiratory Clinical Trials, G7 Countries (%), 2015*
  • Nasal Congestion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nasal Congestion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nasal Congestion to Respiratory Clinical Trials, E7 Countries (%), 2015*
  • Nasal Congestion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nasal Congestion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nasal Congestion Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Nasal Congestion Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nasal Congestion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp & Dohme Corp. (Inactive), 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by McNEIL-PPC, Inc., 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Ache Laboratorios Farmaceuticos S/A, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Acura Pharmaceuticals, Inc., 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bronx-Lebanon Hospital Center, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Pacific Medical Center Research Institute, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2015*
  • Nasal Congestion Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*

List of Figures

  • Nasal Congestion Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Nasal Congestion Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Nasal Congestion to Respiratory Clinical Trials, G7 Countries (%), 2015*
  • Nasal Congestion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nasal Congestion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nasal Congestion to Respiratory Clinical Trials, E7 Countries (%), 2015*
  • Nasal Congestion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nasal Congestion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Nasal Congestion Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nasal Congestion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nasal Congestion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top